Machoń Z, Mielczarek I, Wieczorek J, Mordarski M
Department of Organic Chemistry, Medical Academy, Wrocław.
Arch Immunol Ther Exp (Warsz). 1987;35(5):609-16.
In reactions of 5-aminoisothiazolopyrimidines 1 with glycosilisothiocyanates and phenyl isocyano- or isocyanates, N-glycosilo-N-phenylo- and N-isothiazolopyrimidinothiocarbamides type II were obtained. The same compound--5-aminoisothiazolopyrimidine 1 in reaction with glucose, arabinose and ribose bromoderivatives was converted into N-glycosiloaminoisothiazolopyrimidies type 3. Some of the newly synthetized compounds appeared effective against L-1210 leukemia and Sa-180 sarcoma.
在5-氨基异噻唑并嘧啶1与糖基异硫氰酸酯以及苯基异氰酸酯或异氰酸酯的反应中,得到了II型N-糖基-N-苯基-和N-异噻唑并嘧啶硫代氨基甲酰胺。相同的化合物——5-氨基异噻唑并嘧啶1与葡萄糖、阿拉伯糖和核糖溴衍生物反应,转化为3型N-糖基氨基异噻唑并嘧啶。一些新合成的化合物对L-1210白血病和Sa-180肉瘤显示出有效性。